PLUS THERAPEUTICS, INC. Quarterly Other Assets, Current in USD from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Plus Therapeutics, Inc. quarterly Other Assets, Current history and growth rate from Q4 2010 to Q3 2024.
  • Plus Therapeutics, Inc. Other Assets, Current for the quarter ending September 30, 2024 was $576K, a 18.3% increase year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $576K +$89K +18.3% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $945K +$194K +25.8% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $989K +$83K +9.16% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $1.28M -$2.42M -65.4% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 $487K -$53K -9.82% Sep 30, 2023 10-Q 2023-10-31
Q2 2023 $751K -$48K -6.01% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $906K +$41K +4.74% Mar 31, 2023 10-Q 2023-04-20
Q4 2022 $3.7M +$2.37M +179% Dec 31, 2022 10-K 2024-03-05
Q3 2022 $540K -$277K -33.9% Sep 30, 2022 10-Q 2022-10-20
Q2 2022 $799K -$41K -4.88% Jun 30, 2022 10-Q 2022-07-21
Q1 2022 $865K -$134K -13.4% Mar 31, 2022 10-Q 2022-04-21
Q4 2021 $1.32M +$495K +59.7% Dec 31, 2021 10-K 2023-02-23
Q3 2021 $817K -$99K -10.8% Sep 30, 2021 10-Q 2021-10-21
Q2 2021 $840K +$371K +79.1% Jun 30, 2021 10-Q 2021-07-22
Q1 2021 $999K +$448K +81.3% Mar 31, 2021 10-Q 2021-04-22
Q4 2020 $829K -$128K -13.4% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $916K +$414K +82.5% Sep 30, 2020 10-Q 2020-10-22
Q2 2020 $469K -$34K -6.76% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $551K -$185K -25.1% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 $957K +$172K +21.9% Dec 31, 2019 10-K 2021-02-22
Q3 2019 $502K -$152K -23.2% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $503K -$334K -39.9% Jun 30, 2019 10-Q 2019-08-15
Q1 2019 $736K -$101K -12.1% Mar 31, 2019 8-K 2019-09-10
Q4 2018 $785K +$5K +0.64% Dec 31, 2018 10-K 2020-03-30
Q3 2018 $654K -$238K -26.7% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 $837K -$279K -25% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 $837K +$337K +67.4% Mar 31, 2018 10-Q 2018-05-11
Q4 2017 $780K -$90K -10.3% Dec 31, 2017 8-K 2019-09-10
Q3 2017 $892K -$361K -28.8% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $1.12M -$147K -11.6% Jun 30, 2017 10-Q 2017-08-11
Q1 2017 $500K -$1.37M -73.2% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 $870K -$685K -44.1% Dec 31, 2016 10-K 2018-03-09
Q3 2016 $1.25M -$61K -4.64% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $1.26M +$277K +28.1% Jun 30, 2016 10-Q 2016-08-05
Q1 2016 $1.87M +$522K +38.8% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $1.56M +$563K +56.8% Dec 31, 2015 10-K 2017-03-24
Q3 2015 $1.31M +$69K +5.54% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 $986K -$302K -23.4% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 $1.34M -$47K -3.38% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 $992K -$233K -19% Dec 31, 2014 10-K 2016-03-11
Q3 2014 $1.25M +$117K +10.4% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 $1.29M +$99K +8.33% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 $1.39M +$202K +17% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 $1.23M +$64K +5.51% Dec 31, 2013 10-K 2015-03-16
Q3 2013 $1.13M +$38K +3.49% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 $1.19M +$74K +6.64% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 $1.19M +$54K +4.76% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 $1.16M +$324K +38.7% Dec 31, 2012 10-K 2014-03-14
Q3 2012 $1.09M +$388K +55.3% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 $1.12M +$266K +31.3% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 $1.14M Mar 31, 2012 10-Q 2012-05-10
Q4 2011 $837K +$3K +0.36% Dec 31, 2011 10-K 2013-03-15
Q3 2011 $702K Sep 30, 2011 10-Q 2011-11-08
Q2 2011 $849K Jun 30, 2011 10-Q 2011-08-09
Q4 2010 $834K Dec 31, 2010 10-K/A 2012-09-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.